Science News: ACC 2013 : Sunday

Updated:Mar 28,2013
ACC13-SN email-header-banner
ACC.13  |  Mar. 9 -11, 2013  |  San Francisco, Calif.

Exclusive Science News Videos from ACC.13 

ACC.13 Late-Breaking Clinical Trials II – Session 301
8–9:30 a.m. PDT (UTC-08 hours)

Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in Acute Coronary Syndrome

Anna Toso, MD, Milan, Italy
Presentation slides  | Summary slide | Video interview |Interview MP3 (download)

Related Information

  • ACT Trial, AHA Science News, Sessions 2010: Acetylcystein for the Prevention of Contrast-Induced nephropaThy (ACT) Trial: a Pragmatic Multicenter Randomized Trial to Evaluate the Efficacy of Acetylcysteine for the Prevention of Renal Outcomes in Patients Undergoing Coronary and Vascular Angiography
  • AHA Science News Video - Scientific Sessions 2010

PARTNER 2, Cohort B
A Randomized Evaluation of the SAPIEN XT Transcatheter Valve System in Patients with Aortic Stenosis who are not Candidates for Surgery
Martin Leon, MD, Columbia University Medical Center
Summary Slide 
Related Information
  • PARTNER Cohort B, AHA Science News ACC.11: Lifetime Cost Effectiveness of Transcatheter Aortic Valve Implantation Compared with Standard Care among Inoperable Patients with Severe Aortic Stenosis: Results from the Randomized PARTNER Trial (Cohort B)
  • AHA Science News Video - ACC.11

  • PARTNER, AHA Science News, ACC.11: Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement in "High Risk" Patients with Aortic Stenosis: The Randomized PARTNER Trial
  • AHA Science News Video - ACC.11

One-year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer: the NOBORITM Biolimus-Eluting versus XIENCETM/PROMUSTM Everolimus-eluting Stent Trial

Masahiro Natsuaki, MD, Kyoto University, Japan

Comparison of DK crush versus culotte stenting for unprotected distal left main bifurcation lesions: Results from a multicenter, randomized, prospective DKCRUSH-III study
Junjie Zhang, MD, Nanjing First Hospital, China
Summary slide  |  Video interview (English)  |  Video interview (Chinese) |
Interview MP3 - English (download)  |  Interview MP3 - Chinese (download)

The Main Results of the CHAMPION PHOENIX Trial
Deepak Bhatt, MD, MPH, Harvard University, Boston, Mass.
Presentation slides  |  Summary slide  |  Video interview 

ACC.13 Late-Breaking Clinical Trials II - Session 302
10:45 a.m.–12:15 p.m. PDT (UTC-08 hours)

STrategic Reperfusion Early After Myocardial Infarction

Dr. Frans Van de Werf, Leuven, Belgium

Early Administration of Eplerenone in Patients with Acute Myocardial Infarction Without Heart Failure: Results of the Randomized, Double-Blind, Placebo-Controlled REMINDER Trial
Gilles Montalescot, MD, Pitié-Salpétrière Hospital, Paris
Presentation slides  |  Summary slide  |  Video interview | Interview MP3 (download)

Related Information

  • EMPHASIS-HF, AHA Science News, Sessions 2010: The Effect Of Eplerenone Versus Placebo On Cardiovascular Mortality Or Heart Failure Hospitalization In Subjects With Nyha Class Ii Chronic Systolic Heart Failure
  • AHA Science News Video - Scientific Sessions 2010

  • EMPHASIS-HF, AHA Science News, ESC 2011: The effect of eplerenone versus placebo on cardiovascular mortality or heart failure hospitalization in subjects with NYHA class II chronic systolic heart failure: An analysis of the High-risk groups in the study population
  • AHA Science News Video - ESC 2011

Effects of the P-Selectin Antagonist Inclacumab in the Select Acute Coronary Syndromes Trial
Jean-Claude Tardif, MD, University of Montreal, Canada

Randomized Comparison of High-dose Oral Vitamins vs.Placebo in the Trial to Assess Chelation Therapy - vitamin arm of TACT
Gervasio Lamas, MD, Mount Sinai Medical Center
Summary slide  |  Video interview 

Related Information


Evaluation of Ranolazine in Patients with Type 2 Diabetes Mellitus and Chronic Stable Angina: Results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects with Chronic Stable Angina (TERISA) randomized clinical trial
Dr. Mikhail Kosiborod, St. Luke's, Missouri


Related Statistics:

  • In 2010, the total number of inpatient cardiovascular operations and procedures increased 28%, from 6.0 million in 2000 to 7.6 million in 2010.
  • About 58% of procedures were performed on men, and 51% were performed on people 65 years of age and older.
  • The most common inpatient cardiovascular procedures in 2010 were cardiac catheterization (1.03 million) and angioplasty (955,000) accounting for about 26% of all cardiovascular procedures.

    Learn more in Heart Disease & Stroke Statistics: 2013 Update

    More Exclusive Science News Videos from ACC.13 


Science News on-the-go (ACC13)

Download the below MP3 files and listen to each interview on your mobile, in your own time.
Audio IconACC13 Wrap-Up
Download MP3
Download MP3
MP3 (English)
  |  MP3 (Chinese)
Audio IconSTREAM
MP3 (English) 
Download MP3
Download MP3
Audio IconPREVAIL Discussion
Download MP3
Audio IconTERISA
Download MP3
Audio IconDIOXIN
Download MP3
Audio IconRELAX
Download MP3

Connect with AHA Science News

Follow AHAScience on Twitter (opens in new window)
Like AHA Science News on Facebook (opens in new window)

AHA Science News on YouTube

Subscribe to AHA's Science News Channel (opens in new window) on YouTube for exclusive, late-breaking coverage of over 200 video interviews, panel discussions, welcome messages and more.

Become A Member

Become a professional member of the American Heart Association/American Stroke Association.

Join or renew your AHA/ASA Professional Membership
to qualify for members-only awards, and:

• Affiliate with one of 16 Scientific Councils.
• Save on AHA/ASA Scientific Sessions.
• Save on print publications.
• Apply for research funding and not pay a fee
• Enjoy many more membership benefits.

Promo code: WDJ008ZZ